Concepedia

Xia Zhu

XZ

Statistics

Publications

8

Citations

806

H-Index

8

Active since

2014

Affiliations

Fujian Medical University(Current)

First Affiliated Hospital of Fujian Medical University

Third Affiliated Hospital of Harbin Medical University

Tianjin Medical University Cancer Institute and Hospital

Gansu Provincial Hospital

Xia Zhu is an author at Fujian Medical University specializing in oncology, pharmacology, and medicine.

Publications per year

2014–2020

8

Publications

8

Safety and Efficacy of Anlotinib, a Multikinase Angiogenesis Inhibitor, in Patients with Refractory Metastatic Soft-Tissue Sarcoma

Yihebali Chi, Zhiwei Fang, Xiaonan Hong et al. · Clinical Cancer Research · 2018 · 332 citations

Medicine, Oncology, Pharmacology +17

<p>A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro</p>

Hongxiang Wei, Jinyuan Chen, Shenglin Wang et al. · International Journal of Nanomedicine · 2019 · 317 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Anlotinib for metastasis soft tissue sarcoma: A randomized, double-blind, placebo-controlled and multi-centered clinical trial.

Yihebali Chi, Yang Yao, Shusen Wang et al. · Journal of Clinical Oncology · 2018 · 67 citations

Medicine, Oncology, Pharmacology +15

The clinical significance of the <em>Ezrin</em> gene and circulating tumor cells in osteosarcoma

Guang‐Xian Zhong, Shaodan Feng, Rongkai Shen et al. · OncoTargets and Therapy · 2017 · 24 citations · Full text

Medicine, Cell Biology, Oncology +12

Phase II study of anlotinib for treatment of advanced soft tissues sarcomas.

Yihebali Chi, Yongkun Sun, Jianqiang Cai et al. · Journal of Clinical Oncology · 2016 · 23 citations

Medicine, Oncology, Pharmacology +14

1–5 of 8